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The phenomenon that one cell type can be converted into
another has recently generated much excitement because it
promises to make cell-based therapies feasible. If we man-
age to take skin cells, for instance, and turn them into in-
sulin-producing b cells, dopaminergic neurons, or glia, we
would have a cure for many of the ailments that can render
our lives miserable. But what are the mechanisms that
guide such cellular interconversions?
A basic framework to understand how cells change their
phenotypes is provided by the mechanisms operating dur-
ing development. The development of a cortical neuron, for
instance, occurs by a complex multistep process involving
extracellular signals and the consecutive action of partly
overlapping sets of transcription factors. Among these, one
set keeps neural precursors (cells capable of generating
neurons and glia) in a proliferating stage, another one com-
mits them to the neuronal fate, and a third imparts neuronal
subtype-specific characteristics (Ross et al, 2003). It would
seem, therefore, that the best way to obtain a particular
functional cell type is to start out with the least differentiated
cell and recapitulate normal development. But, given that
some transcription factors such as MYOD or PAX6 are ca-
pable of changing single handedly the phenotypes of many
different cell types (Boukamp, 1995; Halder et al, 1995), it is
tempting to shortcut the process of cellular interconversions
by simply force-expressing such regulators in undifferenti-
ated or even fully or partially differentiated cells. The latter is
what Lanning et al (2005) did when they used a transgenic
mouse approach to express a neurogenic transcription fac-
tor, mammalian achaete-scute homolog-1 (MASH1), under
the control of a tissue-restricted regulatory element in cells
that normally turn into pigment cells. The authors find that in
response to MASH1, one type of pigment cells, retinal pig-
ment epithelium (RPE) cells, initiates neurogenesis whereas
another, melanocytes, does not demonstrably change cell
fate and shows differences only in coloration. These find-
ings raise interesting conceptual and technical questions.
The combination of MASH1 and pigment cells to test cell
type conversions is attractive for several reasons. MASH1
normally serves to promote neuronal differentiation both in
the central and peripheral nervous system (Ross et al, 2003;
Howard, 2005). It belongs to the basic–helix–loop–helix
class of transcription factors that form homo- and hetero-
dimers and specifically bind E box motifs in target pro-
moters. Interestingly, pigment cells likewise depend on a
dimerizing E box-binding transcription factor, microphthal-
mia-associated transcription factor (MITF), a member of
the basic–helix–loop–helix–leucine zipper class of proteins
(Hodgkinson et al, 1993). Importantly, however, the two
proteins do not form DNA-binding heterodimers with each
other and share little interest in each other’s favorite E box-
es, and so it is unlikely that MASH1 would compete directly
with MITF for access to its target genes.
RPE cells are derived from the optic neuroepithelium—
which is part of the central nervous system—and they form a
layer at the back of the eye where they absorb light. Me-
lanocytes are derived from the neural crest—which in addition
gives rise to the peripheral nervous system—and they pop-
ulate various sites including iris, choroid, inner ear, and skin.
Thus, both types of pigment cells have their origin in neu-
rogenic tissue but neither is normally neurogenic itself. More-
over, RPE cells form a contiguous monolayer as does the
early neuroectoderm, and so the mechanisms of fate deter-
mination in the RPE may resemble those leading to the re-
gionalization of the neuroectoderm. In contrast, melanoblasts,
the precursors to melanocytes, are well separated, individual
cells, and so their mechanisms of differentiation may resemble
more closely those specifying individual neurons.
The fundamental differences between the two types
of pigment cells suggest a possible explanation for why
MASH1 is able to convert only one of them into neuronal
tissue. Melanoblasts, in order to reach their final destination,
have to migrate through many different cellular environ-
ments that may induce fluctuations in gene expression, in-
cluding the expression of neurogenic factors. Hence, they
may have been selected evolutionarily not to succumb to
such fluctuations and change their fate too willingly. By
comparison, RPE cells have a stable relationship with their
neighbors, face a constant environment, and may not have
evolved a similar resistance to fate-changing insults that
they may not normally encounter.
Although the above considerations focus on cellular and
molecular interpretations, the results can also be explained
on more technical grounds. Transgenic studies always
present us with the challenge of how best to control trans-
gene expression spatially and temporally. To ensure that
MASH1 is specifically made in cells that have already in-
itiated differentiation towards the pigment lineage, Lanning
et al (2005) link a MASH1 cDNA to the regulatory region of
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the dopachrome tautomerase (Dct) gene which encodes an
enzyme involved in pigment biosynthesis. Evidently, when
the cells switch their phenotype, they lose the expression of
pigment genes. Indeed, transgenic MASH1 suppresses
several pigment gene promoters including the Dct promot-
er, and hence it suppresses its own Dct-driven expression,
leading to unpredictable and variable levels of MASH1.
Therefore, potential quantitative differences between RPE
cells and melanocytes in this negative feedback loop could
explain why the two cell types respond differently to
MASH1. To overcome this problem, one may have to em-
ploy binary transgenic systems such as those based on the
Cre/loxP system, which allows one to first activate gene
expression cell specifically but in a way that it then be-
comes cell type independent and permanent. It is also im-
portant to consider how to achieve accurate dynamic
control of expression. MASH1 is found at low levels in neu-
ral progenitors, at higher levels when they start to differen-
tiate into neurons, and at lower levels again when they
become terminally differentiated. To mimic experimentally
such precise temporal control of expression may require
combinations with drug-mediated regulation. Lastly, regard-
less of whether there are inherent feedback loops, plasmid-
based transgenes are notorious for their cell-to-cell varia-
tion in expression. To overcome this problem, engineered
bacterial artificial chromosomes or gene targeting (knock-
ins) may have to be used, as they allow better insulation
against such variabilities.
The report by Lanning et al (2005) provides a glimpse of
the mechanism by which transgenic MASH1 leads to the
conversion of RPE into neural tissue. The authors show that
MASH1 downregulates MITF, and it has been previously
demonstrated that the downregulation of MITF activity
alone promotes an RPE-to-retina transition (Galy et al, 2002;
Rowan et al, 2004; Horsford et al, 2005). In fact, eyes of Mitf
mutants, including null mutants, sport a fully laminated sec-
ond retina adjacent to the normal one (Nguyen and Arnheiter,
2000). Although transgenic MASH1 is not able to change
RPE all the way to a retina, one might argue that by whatever
mechanism MITF is downregulated, the RPE will always at
least initiate the conversion to neuronal tissue. It is important
to show, therefore, that downregulation of MITF by MASH1
is indeed because MASH1 is neurogenic, as one could im-
agine that the unphysiological expression of many proteins,
neurogenic or not, might have a similar effect on MITF.
The careful histological analysis of the conversion of RPE
into neural tissue reveals an additional subtlety worth men-
tioning. Both Mitf mutations (Nguyen and Arnheiter, 2000)
and MASH1 expression lead to neural formation only in
a limited section of the RPE. In Mitf mutants, conversion
usually involves the dorsal part of the RPE (Nguyen and
Arnheiter, 2000). In MASH1 transgenics, it involves the an-
terotemporal region. In the transgenics, one might explain
this by the peculiarities of mosaic transgene expression, but
in Mitf null mutants, all cells are equally mutant, and so
mosaicism cannot be the reason. Rather, we would argue
that both RPE conversion, and the resistance to it, requires
the cooperation of multiple extrinsic and intrinsic factors.
For instance, conversion could be helped dorsally by dorsal
signals and transcription factors such as Tbx5 (Koshiba-
Takeuchi et al, 2000); and it could be inhibited ventrally by
ventral signals and transcription factors such as VAX1 and
VAX2 (Mui et al, 2005). This reasoning prompts one to set up
specific matings between MASH1 transgenics and mice
carrying different transgenes or mutations in order to delin-
eate the partners with which MASH1 has to collaborate for
more efficient cellular conversions.
In conclusion, the report by Lanning et al (2005) shows
that the neurogenic MASH1 protein can change the fate of
one cell type, RPE, but not that of another, melanocytes.
From a different angle than previous studies, the paper il-
lustrates how dissimilar these two cell lineages are. It is
through such studies that we ultimately gather the knowl-
edge that may lead to a readily harvestable, universal donor
cell type that for cell-based therapies could be tailored to
the needs of individual patients.
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